HyQvia

Takeda casts a new line with first DTC ads for HyQvia in CIDP

Takeda kicked off 2024 by reeling in an approval for HyQvia in CIDP, and it’s closing out the year with its first DTC campaign for the new indication.

Andrea Park Dec 18, 2024 1:01pm

FDA signs off on Takeda's HyQvia as maintenance therapy for CIDP

Jan 16, 2024 11:12am

FDA blesses Takeda's HyQvia to treat children with PI

Apr 12, 2023 10:10am